Triple

T12544132
Position Surface form Disambiguated ID Type / Status
Subject Yamanaka factors E299917 entity
Predicate namedAfter P63 FINISHED
Object Shinya Yamanaka E53130 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Shinya Yamanaka | Statement: [Yamanaka factors, namedAfter, Shinya Yamanaka]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Shinya Yamanaka
Context triple: [Yamanaka factors, namedAfter, Shinya Yamanaka]
  • A. Shinya Yamanaka chosen
    Shinya Yamanaka is a Japanese stem cell researcher and Nobel laureate best known for discovering how to reprogram adult cells into induced pluripotent stem cells, revolutionizing regenerative medicine.
  • B. John B. Gurdon
    John B. Gurdon is a British developmental biologist renowned for his pioneering work in nuclear reprogramming and cloning, which demonstrated that mature cells can be reverted to an embryonic state.
  • C. Mario Capecchi
    Mario Capecchi is an Italian-born American molecular geneticist and Nobel laureate renowned for developing gene targeting in mouse embryonic stem cells, a breakthrough that revolutionized the study of gene function in mammals.
  • D. Sir Martin Evans
    Sir Martin Evans is a British biologist and Nobel Prize–winning pioneer of embryonic stem cell research whose work enabled the development of genetically modified mice for studying human disease.
  • E. Rudolf Jaenisch
    Rudolf Jaenisch is a pioneering molecular biologist known for his groundbreaking work in transgenic animals, epigenetics, and stem cell research.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6ada707008190aaec1238117c9379 completed April 8, 2026, 7:33 p.m.
NER Named-entity recognition batch_69d9547d6df4819080db8415d386ed38 completed April 10, 2026, 7:50 p.m.
NED1 Entity disambiguation (via context triple) batch_69f655801cac8190b1f9a72f8fed0399 completed May 2, 2026, 7:50 p.m.
Created at: April 8, 2026, 9:57 p.m.